Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.

Where this comes from

• Record sourced from PubMed, PMID 42475271.
• Also identified by DOI 10.1371/journal.pone.0354115.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.